GGO Cryoablation Lung Function data
Description
Cryoablation may serve as a safe and feasible option for the treatment of lung nodules mainly composed of GGOs. Forced expiratory volume in the first second (FEV1), forced vital capacity (FVC), and the FEV1/FVC ratio were measured before, 1 week after, and 1 month after the cryoablation treatment. All patients received pulmonary function testing three times and the highest FEV1 value was included in this study. The error rate was less than 5% as determined by measurements recorded in triplicate.
Files
Steps to reproduce
Forced expiratory volume in the first second (FEV1), forced vital capacity (FVC), and the FEV1/FVC ratio were measured before, 1 week after, and 1 month after the cryoablation treatment. All patients received pulmonary function testing three times and the highest FEV1 value was included in this study. The error rate was less than 5% as determined by measurements recorded in triplicate.